Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/1997
10/09/1997CA2250920A1 Photopheresis treatment of chronic hcv infections
10/09/1997CA2250829A1 Method for preventing hiv-1 infection of cd4+ cells
10/09/1997CA2250587A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250460A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250353A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250350A1 Bisarylcyclobutene derivates as cyclooxygenase inhibitors
10/09/1997CA2250204A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250203A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250192A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250190A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250143A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250129A1 Candida albicans tata-binding protein, nucleic acid and assays
10/09/1997CA2249665A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249650A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249645A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249641A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249639A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249617A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249615A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249607A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249605A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249604A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249599A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249559A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2248985A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
10/08/1997EP0799893A1 Defective viral particles obtained in vivo or ex vivo as vaccine
10/08/1997EP0799873A1 Composition for a non-wettable coating, process for treating glazing pane with this composition and the products obtained
10/08/1997EP0799833A1 Erythromycin derivatives, their production and their use as medicaments
10/08/1997EP0799623A2 Medical article with a lubricious coating
10/08/1997EP0799578A2 Combined preparation containing electrolyte enriched germs
10/08/1997EP0799315A2 Telomerase protein component
10/08/1997EP0799311A1 Human chemokine beta-9
10/08/1997EP0799309A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
10/08/1997EP0799242A1 Amphiphilic complexes, method for preparing same and compositions containing such complexes
10/08/1997EP0799241A1 Peptides having immunomodulatory activity
10/08/1997EP0799233A2 Clavulanic acid salts
10/08/1997EP0799232A1 Production of cefotaxime and new sodium salts
10/08/1997EP0799230A1 Thienoxazinone derivatives useful as antiviral agents
10/08/1997EP0799216A1 Substituted thiadiazoles, compositions containing them and their use as antimicrobial and marine antifouling agents
10/08/1997EP0799211A1 2-carbamoyl-1,4,5,6-tetrahydropyrazines
10/08/1997EP0799210A1 Piperazine-2,5-dione derivatives as modulators of multidrug resistance
10/08/1997EP0799188A2 Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor
10/08/1997EP0799047A1 Viscous liquid conditioning topical germicides
10/08/1997EP0799039A1 Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections
10/08/1997EP0799037A1 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
10/08/1997EP0799033A1 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
10/08/1997EP0580782B1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof
10/08/1997EP0544757B1 Novel polyamine conjugated oligonucleotides
10/08/1997CN1161652A Pharmaceutical compositions
10/08/1997CN1161337A Water soluble rapamycin esters
10/08/1997CN1161328A Aminoalkyl subsetd. benzo-heterocyclic compounds
10/08/1997CN1161211A Syrup for curing cold syndrome in women's lower abdomen, and method for preparing same
10/07/1997US5675003 3-ammoniopropenyl cephalosporin compounds as antibacterial agents
10/07/1997US5674988 Inhibition of influenza virus neuraminidase
10/07/1997US5674984 Method for isolation of unclipped HIV envelope protein
10/07/1997US5674858 Medicaments for treating gastrointestinal disorders
10/07/1997US5674856 Modified oligodeoxyribonucleoditides
10/07/1997US5674840 Synthetic aglucodalbaheptide antibiotics
10/07/1997US5674834 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
10/07/1997US5674736 Salmonella virulence genes
10/07/1997US5674724 Mutating the phoq gene to cause a gene under control of phop/phoq regulatort region to be expressed constitutively
10/07/1997US5674708 Amino acid at position 358 is selected from the group consisting of isoleucine, valine, alanine, aspartic acid, threonine and glutamic acid
10/07/1997US5674681 Detecting association of a nonclassical major histocompatibility complex with a beta2 microglobin
10/07/1997US5674676 HCV peptide antigens and method of determining HCV
10/07/1997US5674537 Electrolyzed saline solution containing concentrated amounts of ozone and chlorine species
10/07/1997US5674502 Cross-reactive influenza a immunization
10/07/1997US5674500 Vaccines against Aujeszky's disease and other animal diseases containing pseudorabies virus mutants
10/07/1997US5674499 Equine herpesvirus gene 15 mutants
10/07/1997US5674490 Culture product from streptomyces hygroscopicus fermented under submerged aerobic conditions; azalomycin class
10/07/1997CA2030166C Pradimicin derivatives
10/07/1997CA2009637C Substituted-1,3-oxathiolanes with antiviral properties
10/02/1997WO1997035997A2 Recombinant pox virus encoding myelin protein for therapy
10/02/1997WO1997035877A1 Antibiotic peptides from bovine milk
10/02/1997WO1997035856A1 Novel treatment for cns injuries
10/02/1997WO1997035855A1 Novel treatment for cns injuries
10/02/1997WO1997035619A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
10/02/1997WO1997035613A1 Method of producing immunogenic products and vaccines
10/02/1997WO1997035611A1 Stationary phase, stress response sigma factor from mycobacterium tuberculosis, and regulation thereof
10/02/1997WO1997035587A1 Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs
10/02/1997WO1997035581A1 Interleukin-6 production inhibitor
10/02/1997WO1997035538A2 Tumor necrosis factor alpha convertase
10/02/1997WO1997035480A1 Method of treating common cold or allergic rhinitis
10/02/1997WO1997031117A3 A human cytomegalovirus combined antigen and its use
10/02/1997WO1997026331A3 Use of neuronal apoptosis inhibitor protein (naip)
10/02/1997DE19612966A1 Tierische Zellen und Verfahren zur Vermehrung von Influenzaviren Animal cells and processes for replication of influenza viruses
10/02/1997DE19612807A1 Neue Benzaldehyd-Derivate aus Hericeum erinaceus New benzaldehyde derivatives from Hericeum erinaceus
10/02/1997DE19612805A1 Antifungische Peptide aus Scleroderma texense Texense antifungal peptides from Scleroderma
10/02/1997CA2250058A1 Recombinant pox virus encoding myelin protein for therapy
10/02/1997CA2249985A1 Tumour necrosis factor alpha convertase
10/02/1997CA2249652A1 Method of treating common cold or allergic rhinitis
10/02/1997CA2249354A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
10/02/1997CA2249208A1 Stationary phase, stress response sigma factor from mycobacterium tuberculosis, and regulation thereof
10/01/1997EP0797995A2 Use of a 5-HT2 receptor antagonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis
10/01/1997EP0797917A1 Iodine/resin disinfectant and a procedure for the preparation thereof
10/01/1997EP0797667A1 Papillomavirus vaccine
10/01/1997EP0797660A1 Human immunodeficiency virus vaccines and therapeutics containing replication-impaired hiv-1 nef-deletion mutants
10/01/1997EP0797586A1 NOVEL MEMBRANE PROTEINE p76 OF HELICOBACTER PYLORI
10/01/1997EP0797585A1 Helicobacter lactoferrin receptor
10/01/1997EP0797579A1 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity
10/01/1997EP0797576A1 Alkyl substituted piperadinyl and piperazinyl anti-aids compounds
1 ... 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 ... 1798